Skip to content

Effect of Magnet treatment in Head injury patients

Effect of rTMS on cognitive functioning in moderate traumatic brain injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/02/007789
Enrollment
40
Registered
2017-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S098- Other specified injuries of head Health Condition 2: null- Patients with moderate traumatic brain injury

Interventions

Intervention1: Repetitive transcranial magnetic stimulation: Frequency
10-Hz at 110% threshold with 20 x 5-sec trains. Patient will recieve a total of 20 sessions over a period of 4 weeks Control Intervention1: sham-repetitive transcranial stimulation(Plecebo): Patient

Sponsors

All india institute of medical science
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Moderate TBI patients (defined as: GCS score: 9-12, History of post traumatic amnesia 1 day > to 30 minutes to Age between 18-65 yrs Males educated at least up to 10th standard Suffered TBI within last one month Willing to provide written informed consent to participate in study

Exclusion criteria

Exclusion criteria: Have a mass lesion, cerebral infarct or other active CNS disease. Past/current history of seizure disorder . Presence of past (through history)/current (MINI) Axis I disorders including substance abuse/dependence (other than caffeine or nicotine). Receiving any psychotropic except anti-epileptics Patients receiving or received any surgical procedures on brain . Patients with implanted device or metal in the brain/head or cardiac pacemaker. Facial tattoos with metallic or magnetic-sensitive ink.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be difference in cognitive functioning in patients receiving active rTMS as compaired to control patients receiving sham-rTMSTimepoint: After 5th and 20th sessions of rTMS.

Secondary

MeasureTime frame
To explore the safety and tolerability.Timepoint: After 5th and 20th sessions of rTMS.

Countries

India

Contacts

Public ContactTashi Tundup

All india institute of medical science

nandkm2001@gmail.com09868397137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026